• SENSEX 82,184.17
    -542.47 (--0.66%)
  • BANKNIFTY 57,066.05
    -144.40 (--0.25%)
  • Olectra Greentec
    1,590.00 1,786.65(%)
  • Kajaria Ceramics
    1,171.20 745.00(%)
  • Jayaswal Neco
    49.11 55.34(%)
  • Eternal Ltd
    314.40 314.40(%)
  • Force Motors
    20,563.00 20,563.00(%)
  • Kilburn Engg.
    546.50 546.50(%)
  • One 97
    1,128.00 1,128.00(%)
  • Tata Motors
    706.50 1,179.05(%)
  • Datamatics Glob.
    945.70 945.70(%)
  • Bombay Dyeing
    196.50 256.25(%)
  • Indian Energy Ex
    131.50 131.50(%)
  • Kotak Mah. Bank
    2,140.00 1,679.10(%)
  • Swiggy
    429.90 617.00(%)
  • Coforge
    1,670.70 1,120.01(%)
  • Canara Bank
    114.00 119.30(%)
  • Waaree Energies
    3,266.00 3,740.75(%)
  • Tilaknagar Inds.
    505.00 505.00(%)
  • Persistent Sys
    5,084.15 4,163.80(%)
  • Infosys
    1,548.20 1,307.10(%)
  • Ola Electric
    42.36 39.58(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gennex Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Prudential
  • BSE Code : 14707.0
  • ISIN : INE509C01026
13.42 0 (1.59%)
  • As on 25 Jul 2025 (EOD)

  • Today’s Low

    13.21

  • Today’s High

    13.50

  • Open

    13.45

  • Perv Close

    13.21

  • 52W Low

    11.15

  • 52W High

    29.00

Key Indicators

  • P/E(TTM)

    21.65

  • Mar.Cap (₹Cr.)

    305.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.87

  • Debt-Equity Ratio

    1.59

  • AGM Date

    24-Jul-2025

  • EPS

    0.62

  • P/E Ratio

    21.65

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    305.23

  • RONW (%)

    10.51

  • ROCE (%)

    13.64

Score Board

  • Equity (₹ in Cr.)

    22.74

  • BV (₹)

    7.90

  • Sales( ₹ in Cr.)

    94.58

  • NP (in Cr.)

    14.16

  • NP Var(%)

    20.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    305.23

  • 52 Week High

    29.00

  • 52 Week Low

    11.15

  • Price BSE

    13.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    305.23

  • P/C Ratio

    19.80

  • P/E Ratio

    20.90

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 74.05 71.35 65.26 63.65 59.96 59.96
Excise Duty 7.25 6.25 4.05 4.00 4.34 4.16
Net Sales 66.80 65.10 61.21 59.65 55.62 55.80
Other Income 4.30 3.40 1.38 0.52 1.06 0.78
Stock Adjustments 2.44 7.00 1.91 -1.53 1.51 2.39
Total Income 73.54 75.50 64.50 58.64 58.19 58.97
EXPENDITURE :            
Raw Materials 41.94 48.14 41.23 35.18 36.20 36.31
Power and Fuel Cost 3.29 4.26 3.17 3.01 3.30 2.85
Employee Cost 6.05 7.71 6.97 7.21 6.81 6.12
Other Manufacturing Expenses 1.06 1.18 0.80 2.14 3.67 3.97
Selling and Administration Expenses 2.93 4.40 3.43 3.44 3.34 4.23
Miscellaneous Expenses 1.54 1.82 2.15 0.98 0.56 0.69
Employee Benefit Expenses 6.05 7.71 6.97 7.21 6.81 6.12
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 56.81 67.51 57.74 51.96 53.88 54.17
Operating Profit 16.73 7.99 6.76 6.68 4.30 4.80
Interest 1.16 1.23 0.88 0.74 0.75 0.79
Gross Profit 15.57 6.76 5.88 5.94 3.55 4.01
Depreciation 0.81 0.74 0.79 0.88 1.00 0.98
Profit Before Tax 14.76 6.02 5.09 5.06 2.55 3.03
Current Tax 3.05 1.59 1.32 1.27 0.85 0.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.09 -0.14 -0.15 -0.25 -0.16 -0.05
Reported Net Profit 11.80 4.56 3.92 4.04 1.86 2.22
Extraordinary Items 0.00 0.04 0.00 -0.28 0.08 0.00
Adjusted Net Profit 11.80 4.52 3.92 4.32 1.78 2.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 28.22 23.66 19.74 15.70 13.84 11.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 40.02 28.22 23.66 19.74 15.70 13.84
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.52 0.25 0.31 0.32 0.15 0.18
Earnings Per Share(Adj)-Unit Curr 0.52 0.25 0.30 0.31 0.14 0.17
Book Value 7.26 4.39 3.48 3.15 2.83 2.69
Book Value(Adj)-Unit Curr 7.26 4.39 3.32 3.00 2.69 2.57

Shareholding Pattern

  • Promoter Group

    19.83%

  • Public Share Holding

    80.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 45,071,874 19.47 41,071,874 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 48,300 0.02 48,300 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 765,450 0.33 765,450 1
Others 0 0.00 0 0
Sub Total 45,885,624 19.83 41,885,624 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 3,600 0.00 3,600 1
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,600 0.00 3,600 1
2] Non Institution
Bodies Corporate 26,441,317 11.42 26,439,317 250
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 8,242,536 3.56 8,242,536 791
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 38,115,556 16.47 38,115,556 69
Individuals holding nominal share capital up to Rs. 1 lakh 105,143,070 45.43 103,118,740 89,984
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 123,850 0.05 123,850 4
Others 0 0.00 0 0
Sub Total 185,558,450 80.17 183,532,120 91,173
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 231,447,674 100.00 225,421,344 91,183

Company Background

Gennex Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Gennex Laboratories Ltd
  • BSE Code : 14707.0
  • ISIN : INE509C01026

  • Incorporation Year

    1990

  • Registered Office

    Survey No 133 Bollaram
    Jinnaram Mandal, Medak,
    Telangana-502325

  • Telephone

    91-8458-279406/279516

  • FAX

  • Chairman

    Arihant Baid

  • Managing Director

    Arihant Baid

  • Company Secretary

    Dinesh Kumar Kejriwal.

  • Auditor

    R Pugalia & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    R & D Infotech Pvt Ltd
    7A Betala Road,
    1st Floor,
    Mumbai - Kolkata - 700 026

Gennex Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gennex Lab. 13.42 71.10 74.05 21.65 12.50
Abbott India 34,635.25 6,684.73 6,409.15 52.03 44.95
Astrazeneca Phar 9,021.20 1,756.92 1,716.29 194.84 32.94
P & G Health Ltd 5,829.95 1,166.89 1,151.26 38.53 39.76
Glaxosmi. Pharma 3,159.95 3,866.05 3,723.49 58.25 58.72
Cipla 1,487.25 20,029.57 19,044.85 23.29 21.40
Amrutanjan Healt 700.40 437.58 421.23 39.84 20.84
Fermenta Biotec. 383.00 442.21 430.53 16.67 17.61
Guj. Themis Bio. 363.15 174.19 169.82 81.06 44.82
Bliss GVS Pharma 152.90 703.42 667.20 23.38 9.16
Ambalal Sarabhai 34.63 19.33 4.04 32.06 2.10